Setoguchi, Soko

Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

Ferrari, A. J., Santomauro, D. F., Aali, A., Abate, Y. H., Abbafati, C., Abbastabar, H., Abd ElHafeez, S., Abdelmasseh, M., Abd-Elsalam, S., Abdollahi, A., et al. (2024) · The Lancet

Global Health and EpidemiologyInsurance, Mortality, Demography, Risk Management

Cited by 5,112

Risk of death associated with the use of conventional versus atypical antipsychotic drugs among elderly patients

Schneeweiss, S., Setoguchi, S., Brookhart, A., Dormuth, C., & Wang, P. S. (2007) · Canadian Medical Association Journal

Schizophrenia research and treatmentPharmaceutical Practices and Patient Outcomes

Cited by 366

Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis

Greenberg, J. D., Kremer, J. M., Curtis, J. R., Hochberg, M. C., Reed, G., Tsao, P., Farkouh, M. E., Nasir, A., Setoguchi, S., & Solomon, D. H. (2011) · Annals of the Rheumatic Diseases

Rheumatoid Arthritis Research and TherapiesInflammatory mediators and NSAID effects

Cited by 350

Effectiveness and safety of warfarin initiation in older hemodialysis patients with incident atrial fibrillation

Winkelmayer, W. C., Liu, J., Setoguchi, S., & Choudhry, N. K. (2011) · Clinical Journal of the American Society of Nephrology

Atrial Fibrillation Management and OutcomesAcute Ischemic Stroke Management

Cited by 280

Bone mineral density in subjects using central nervous system-active medications

Kinjo, M., Setoguchi, S., Schneeweiss, S., & Solomon, D. H. (2005) · The American Journal of Medicine

Bone health and osteoporosis researchPharmaceutical Practices and Patient Outcomes

Cited by 191

Cardiovascular outcomes with SGLT2 inhibitors versus DPP4 inhibitors and GLP-1 receptor agonists in patients with heart failure with reduced and preserved ejection fraction

Gonzalez, J., Bates, B. A., Setoguchi, S., Gerhard, T., & Dave, C. V. (2023) · Cardiovascular Diabetology

Diabetes Treatment and ManagementHeart Failure Treatment and Management

Cited by 32

Comparing record linkage software programs and algorithms using real-world data.

Karr, A. F., Taylor, M. T., West, S. L., Setoguchi, S., Kou, T. D., Gerhard, T., & Horton, D. B. (2019) · PLOS ONE

Data Quality and ManagementMedical Coding and Health Information

Cited by 27

Trends in Prescribing Preferences for Antidiabetic Medications Among Patients With Type 2 Diabetes in the U.K. With and Without Chronic Kidney Disease, 2006–2020

Liaw, J., Harhay, M., Setoguchi, S., Gerhard, T., & Dave, C. V. (2022) · Diabetes Care

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 21